| |
Demonstrate knowledge of the evolving roles of afferents and efferents in the pathophysiology of OAB, focusing on urgency as the core symptom |
| |
Evaluate the important role that dose titration can play for the individual OAB patient and employ a patient-centered treatment strategy that explores the benefits of dosing antimuscarinics to obtain a balance between efficacy and tolerability
|
| |
Analyze patient-reported outcomes instruments, and confidently use them to assess an OAB patient’s symptoms, symptom severity, health-related quality of life, and treatment satisfaction |
| |
Dissect the efficacy and safety of alternative pharmacologic approaches to antimuscarinics in OAB |